Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998–2021)
- 12 January 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 230, 114119
Abstract
No abstract availableKeywords
This publication has 129 references indexed in Scilit:
- Discovery of the Selective Androgen Receptor Modulator MK-0773 Using a Rational Development Strategy Based on Differential Transcriptional Requirements for Androgenic Anabolism Versus Reproductive PhysiologyJournal of Biological Chemistry, 2010
- Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous GlandsJournal of Biological Chemistry, 2009
- Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulatorsBioorganic & Medicinal Chemistry Letters, 2008
- Discovery and biological characterization of a novel series of androgen receptor modulatorsBritish Journal of Pharmacology, 2008
- Potent, nonsteroidal selective androgen receptor modulators (SARMs) based on 8H-[1,4]oxazino[2,3-f]quinolin-8-onesBioorganic & Medicinal Chemistry Letters, 2007
- Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)Drug Discovery Today, 2007
- Selective Androgen Receptor Modulator (SARM) Treatment Prevents Bone Loss and Reduces Body Fat in Ovariectomized RatsPharmaceutical Research, 2006
- Structure of the ligand-binding domain (LBD) of human androgen receptor in complex with a selective modulator LGD2226Acta Crystallographica Section F Structural Biology and Crystallization Communications, 2006
- Structural Basis for Accommodation of Nonsteroidal Ligands in the Androgen ReceptorJournal of Biological Chemistry, 2005
- Chemistry and Structural Biology of Androgen ReceptorChemical Reviews, 2005